The judge in the Purdue Pharma bankruptcy proceedings has said he will approve the OxyContin maker’s reorganisation plan, which resolves thousands of opioid lawsuits and comes against a backdrop of Purdue suing its insurers earlier this year.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: